AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27236884
Drug: Acupuncture combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture combined with medicine (ACM) - electro-acupuncture combined with injection of dexmedetomidine
Trial: 27236884
Drug: Conventional analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional analgesia - injection of dexmedetomidine
Trial: 24872682
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (compression therapy and surgery)
Trial: 22772512
Drug: Haloperidol-propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Haloperidol-propofol infusion
Trial: 22772512
Drug: Midazolam-propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Midazolam-propofol infusion
Trial: 11978287
Drug: Isotretinoin at
RxNorm normalized name: Isotretinoin
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isotretinoin at 0.5 mg/kg per day for 6 months
Trial: 10760294
Drug: DHEA, 50
RxNorm normalized name: DHEA, 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA, 50 mg, orally, daily for a year
Trial: 8933125
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (4 g oil per day for 15 weeks)
Trial: 8933125
Drug: DHA-rich oil
RxNorm normalized name: Ulkenia DHA oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA-rich oil (4 g oil per day for 15 weeks)
Trial: 1434268
Drug: Oral prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prostaglandin E1 (limaprost)
Trial: 30690085
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy regimens (41 identified)
Trial: 27328311
Drug: Nutritional intervention
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional intervention (oral supplementation)
Trial: 24738467
Drug: Shuganyiyang Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shuganyiyang Capsules
Trial: 24738467
Drug: Tadalafil +
RxNorm normalized name: Tadalafil
DrugBank: Tadalafil (DB00820)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tadalafil + Shuganyiyang Capsules
Trial: 31008751
Drug: Dexmedetomidine (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (all doses)
Trial: 31671191
Drug: Durvalumab and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Durvalumab and chemotherapy (high PD-L1 expression)
Trial: 31671191
Drug: Durvalumab, tremelimumab,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Durvalumab, tremelimumab, and chemotherapy (low PD-L1 expression)
Trial: 17370714
Drug: Dietary restriction
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary restriction and physical activity with behaviour therapy
Trial: 17370714
Drug: Anti-obesity drugs
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-obesity drugs
Trial: 17370714
Drug: Treatment programmes
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment programmes
Trial: 11120972
Drug: Concentration-controlled therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concentration-controlled therapy (11 subjects)
Trial: 11120972
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (13 subjects)
Trial: 26493461
Drug: Home-based exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based exercise programme delivered through a tablet computer, 2 hours of exercises per week for 2 years.
Trial: 26493461
Drug: Education programme
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Education programme focused on health-related information relevant to older adults, delivered through the tablet computer via weekly fact sheets.
Trial: 18643839
Drug: Basal-bolus therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal-bolus therapy (insulin detemir once daily and insulin aspart mealtimes)
Trial: 18643839
Drug: Biphasic insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Biphasic insulin aspart 30 (30% rapid-acting insulin aspart), twice daily
Trial: 17848650
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of folic acid (40 mg), pyridoxine hydrochloride (100 mg), and cyanocobalamin (2 mg) daily
Trial: 17848650
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of folic acid and B vitamins
Trial: 9141924
Drug: Alfentanil (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil (40 micrograms/kg IV bolus) followed by infusion (1 microgram.kg‐1.min‐1 during surgery and 0.5 microgram.kg‐1.min‐1 postoperatively)
Trial: 9141924
Drug: Sufentanil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil (5 micrograms/kg IV bolus) followed by infusion (0.01 microgram.kg‐1.min‐1 during surgery and 0.005 microgram.kg‐1.min‐1 postoperatively)
Trial: 9355669
Drug: Prednisone (more
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (more than 0.16 mg/kg/day for more than 6 months)
Trial: 2852609
Drug: Fluconazole, single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole, single oral 150 mg dose
Trial: 2852609
Drug: Ketoconazole, 200
RxNorm normalized name: Ketoconazole, 200 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole, 200 mg twice daily for 5 days
Trial: 30445389
Drug: Unified Protocol
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders (UP)
Trial: 30445389
Drug: Waitlist/Treatment-as-Usual (WL/TAU)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Waitlist/Treatment-as-Usual (WL/TAU)
Trial: 23963046
Drug: Sildenafil (doses:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (doses: 37.5 mg, 50 mg, 100 mg)
Trial: 15785088
Drug: Acyclic retinoid
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclic retinoid (oral administration for 12 months)
Trial: 12034658
Drug: Losartan treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan treatment for 12 months in patients with severe fibrosis (n=7)
Trial: 7790707
Drug: Propylthiouracil (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propylthiouracil (300 mg)
Trial: 2220013
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg pimobendan
Trial: 2220013
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg pimobendan
Trial: 87829
Drug: 2-month regimen
RxNorm normalized name: Anacin Aspirin Regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-month regimen of chemotherapy (daily streptomycin, isoniazid, rifampicin, and pyrazinamide)
Trial: 87829
Drug: 3-month regimen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-month regimen of chemotherapy (daily streptomycin, isoniazid, rifampicin, and pyrazinamide)
Trial: 24284610
Drug: Chewable tablet
RxNorm normalized name: Chewable Tablet
DrugBank: Bismuth subsalicylate (DB01294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chewable tablet (200 mg vitamin C)
Trial: 24284610
Drug: Kiwifruit-derived vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kiwifruit-derived vitamin C (equivalent dose from gold kiwifruit)
Trial: 24284610
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C tablet
Trial: 15496648
Drug: Amprenavir-containing combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amprenavir-containing combination therapy with nucleoside reverse transcriptase inhibitors
Trial: 3501546
Drug: Oral leucovorin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral leucovorin calcium (5-formyl-THF) at doses of 40 mg, 60 mg, 80 mg, and 100 mg
Trial: 3501546
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg oral leucovorin calcium
Trial: 3501546
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg intravenous leucovorin calcium
Trial: 3501546
Drug: Oral leucovorin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral leucovorin calcium
Trial: 29180640
Drug: CSII therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSII therapy
Trial: 29215299
Drug: MDI therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDI therapy
Trial: 29215299
Drug: CSII therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSII therapy at 12 months
Trial: 29215299
Drug: CSII therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSII therapy after crossover from MDI
Trial: 24766974
Drug: Amiodarone (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone (up to 450 mg)
Trial: 24766974
Drug: Lidocaine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (up to 180 mg)
Trial: 12548295
Drug: 100 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g/day of berries (black currants, lingonberries and bilberries) for 8 weeks
Trial: 8403586
Drug: Sustained-release flurbiprofen
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release flurbiprofen 200 mg
Trial: 2906886
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg acrivastine given three times daily
Trial: 2906886
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg acrivastine given three times daily
Trial: 2906886
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg clemastine given three times daily
Trial: 25322607
Drug: Dexmedetomidine low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine low maintain dose (0.2 microg x kg(‐1) x h(‐1))
Trial: 25322607
Drug: Dexmedetomidine high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine high maintain dose (0.7 microg x kg(‐1) x h(‐1))
Trial: 22566538
Drug: Zinc (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc (10 mg)
Trial: 20484548
Drug: Iron +
RxNorm normalized name: Celebrate Iron + C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron + Folic Acid (12.5 mg iron + 50 microg folic acid)
Trial: 20484548
Drug: Zinc +
RxNorm normalized name: GNP Cal Mag Zinc + D Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc + Iron + Folic Acid (10 mg zinc + 12.5 mg iron + 50 microg folic acid)
Trial: 14572943
Drug: Video presentations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Video presentations about nicotine replacement treatment (NRT)
Trial: 10470219
Drug: Inhaled IL-2
RxNorm normalized name: Ile
DrugBank: Isoleucine (DB00167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled IL-2 (high-dose)
Trial: 7567847
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (Control group, n = 25)
Trial: 1770153
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg of alprazolam
Trial: 25848210
Drug: HX‐1171, single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HX‐1171, single ascending doses of 20, 40, 80, 160, 300, 600, 1,200, 1,500 or 2,000 mg administered to 67 subjects.
Trial: 25848210
Drug: HX‐1171, multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HX‐1171, multiple ascending doses of 500 or 1,000 mg administered to 16 subjects for 14 days.
Trial: 25848210
Drug: HX‐1171, single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HX‐1171, single and multiple doses.
Trial: 21084767
Drug: Ammonium chloride
RxNorm normalized name: Ammonium Chloride
DrugBank: Ammonium chloride (DB06767)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ammonium chloride treatment
Trial: 30237219
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate treatment
Trial: 21084767
Drug: Ammonium chloride
RxNorm normalized name: Ammonium Chloride
DrugBank: Ammonium chloride (DB06767)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ammonium chloride treatment (PEPT2*2/*2)
Trial: 21084767
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate treatment (PEPT2*1/*1)
Trial: 19861194
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (oral group)
Trial: 17978987
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of denicotinized cigarettes (Quest 3) and 21‐mg nicotine patch for 2 weeks before the quit date
Trial: 15195985
Drug: Home training
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home training (HT) - twice‐daily functional balance and strength exercises and 3 group meetings
Trial: 15195985
Drug: Combined training
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined training (CT) - group training twice weekly and the same home exercises
Trial: 9152568
Drug: 20-mg SR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-mg SR morphine sulfate capsule administered while fasting
Trial: 9152568
Drug: 20-mg SR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-mg SR morphine sulfate capsule administered after a high-fat meal
Trial: 7525038
Drug: Pamidronate 60
RxNorm normalized name: pamidronate 60 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pamidronate 60 mg every 4 weeks
Trial: 3496872
Drug: Oral erythromycin
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral erythromycin (25 mg/kg twice daily for 14 days)
Trial: 1448311
Drug: Topical chloramphenicol
RxNorm normalized name: chloramphenicol Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical chloramphenicol
Trial: 3496872
Drug: Severe conjunctivitis
RxNorm normalized name: acetaminophen / diphenhydramine hydrochloride Oral Tablet [Tylenol Severe Allergy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Severe conjunctivitis treatment
Trial: 29945711
Drug: Progesterone 200
RxNorm normalized name: progesterone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progesterone 200 mg vaginally daily from 22+0 to 24+0 weeks until 34+0 weeks' gestation
Trial: 26441180
Drug: Laparoscopic rectal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopic rectal resection (n=238)
Trial: 26441180
Drug: Open laparotomy
RxNorm normalized name: BOTTLE OPENER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open laparotomy and rectal resection (n=237)
Trial: 20951235
Drug: Exposure-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure-based therapy for PTSD delivered via telehealth technology
Trial: 20951235
Drug: Exposure-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure-based therapy for PTSD delivered in-person
Trial: 18468736
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract (GTE) 400mg, three times daily for 12 weeks
Trial: 8866928
Drug: Nebulized morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized morphine (50 mg in 4 ml saline)
Trial: 8866928
Drug: Oral morphine
RxNorm normalized name: morphine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral morphine (10 mg solution)
Trial: 9552779
Drug: Intravenous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous morphine (5 mg)
Trial: 6403140
Drug: Glucose polymer
RxNorm normalized name: glucose polymers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose polymer supplementation (Caloreen) at 6 g/kg body weight daily
Trial: 29506460
Drug: Conventional group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional group (antibiotics stopped according to physicians' discretion)
Trial: 25074713
Drug: Dermal scarification
RxNorm normalized name: Dermal-Soothe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermal scarification (1 ml normal saline injection)
Trial: 18981503
Drug: rDEN4Delta30-200,201 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rDEN4Delta30-200,201 vaccine (10^5 PFU)
Trial: 9825368
Drug: Propafenone (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone (600 mg single oral dose)
Trial: 2664816
Drug: Amoxycillin/clavulanic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin/clavulanic acid (1 g amoxycillin/200 mg clavulanic acid, 3 to 4 intravenous doses per day for mean 7.7 days, followed by 500 mg amoxycillin/125 mg clavulanic acid, 4 to 6 tablets per day for mean 11.2 days)
Trial: 2664816
Drug: Standard regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard regimen (3 to 4 g amoxycillin or ampicillin, 160 mg gentamicin, and 1.5 g metronidazole, parenteral therapy for mean 7.7 days, followed by 2 to 3 g amoxycillin or ampicillin and 1 to 1.5 g metronidazole daily for mean 11.1 days)
Trial: 31385202
Drug: Choline plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choline plus magnesium (1000 mg choline bitartrate and 500 mg magnesium oxide)
Trial: 31385202
Drug: Magnesium (500
RxNorm normalized name: magnesium gluconate 27 mg magnesium (500 mg) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium (500 mg magnesium oxide)
Trial: 31385202
Drug: Choline (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choline (1000 mg choline bitartrate)
Trial: 29904752
Drug: HEMA-free 1-step
RxNorm normalized name: Free Cysteine
DrugBank: Cysteine (DB00151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: HEMA-free 1-step self-etch adhesive (1SEa G-Bond)
Trial: 24214373
Drug: Atorvastatin 20
RxNorm normalized name: atorvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 20 mg single oral dose
Trial: 17976224
Drug: Inhaled iloprost
RxNorm normalized name: iloprost Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled iloprost (25 microg)
Trial: 16620263
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen therapy (202.65 kPa for 90 min, 5 days a week for 4 weeks)
Trial: 16620263
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no hyperbaric therapy)
Trial: 12568840
Drug: Oral 17beta‐E(2)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 17beta‐E(2) administration from cycle day 20 until the next cycle day 2.
Trial: 12568840
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no E(2) administration).
Trial: 11689712
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (LMWH) certoparin, self-administered for 3 months
Trial: 9130335
Drug: Ethanol (0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0.9 g/kg)
Trial: 3147477
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg zolpidem (ZOL)
Trial: 3147477
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg chlorpromazine (CPZ)
Trial: 3147477
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ZOL + CPZ
Trial: 1771605
Drug: Terbutaline (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (1 mg) via metered dose inhaler
Trial: 1771605
Drug: Terbutaline (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (2 mg total: 1 mg from each inhaler) via both inhalers
Trial: 1771605
Drug: Terbutaline (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (1 mg) via dry powder inhaler
Trial: 1771605
Drug: Terbutaline via
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline via metered dose inhaler
Trial: 1771605
Drug: Terbutaline (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (1 mg) via both inhalers
Trial: 20518813
Drug: Effervescent tablets
RxNorm normalized name: Hydralyte Effervescent Tablets Berry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Effervescent tablets
Trial: 23885993
Drug: High-lignan FLX
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-lignan FLX (0.41 g lignans)
Trial: 23885993
Drug: Regular FLX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular FLX (0.15 g lignans)
Trial: 21157106
Drug: atorvastatin 40mg
RxNorm normalized name: AMLODIPINE 5MG/ATORVASTATIN 40MG TAB
DrugBank: Atorvastatin (DB01076)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: atorvastatin 40mg